A Colon Cancer Organoid-on-a-Chip Model for In Vitro Therapy Assessment

Area of Science:

• Oncology
• Biomedical Engineering
• Microfluidics

Background:

• Colorectal cancer poses a significant global health challenge, necessitating innovative drug development strategies.
• Conventional cell culture models fail to replicate the tumor microenvironment, hindering therapeutic research.
• Patient-derived organoids offer a more physiologically relevant in vitro model for cancer research.

Purpose of the Study:

• To develop and validate a novel colon cancer organoid-on-a-chip system.
• To enable continuous culture and real-time monitoring of patient-derived colon cancer organoids.
• To assess the efficacy of standard chemotherapies within this advanced in vitro model.

Main Methods:

• Patient-derived colon cancer organoids were established from tumor biopsies.
• Organoids were cultured within a microfluidic chip designed as a bioreactor.
• Continuous media flow and real-time optical microscopy were employed for monitoring.
• In vitro drug screening using 5-fluorouracil and oxaliplatin combinations was performed.

Main Results:

• Successful integration and continuous culture of patient-derived colon cancer organoids in a microfluidic chip.
• Demonstration of real-time monitoring of organoid response to therapies.
• Validation of the organoid-on-a-chip model for in vitro testing of colon cancer drug efficacy.

Conclusions:

• The developed colon cancer organoid-on-a-chip model represents a significant advancement in cancer research.
• This technology enhances the physiological relevance of in vitro models for drug screening.
• The system shows promise for improving personalized medicine approaches in colorectal cancer treatment.